US FDA approves Enspryng from Genentech for neuromyelitis optica spectrum disorder EP News Bureau Aug 16, 2020 In two randomised controlled Phase III clinical trials, SAkuraStar and SAkuraSky studies, Enspryng demonstrated robust and…
US FDA grants approval of Uplizna to Viela Bio EP News Bureau Jun 12, 2020 Uplizna is the second FDA approved therapy for Neuromyelitis Optica Spectrum Disorder which offers patients additional treatment…
